南美洲输血诊断市场预测至 2028 年 - COVID-19 影响和按产品(仪器、试剂盒和试剂)、应用(血型和疾病筛查)和最终用户(医院、诊断实验室、血库和血浆)进行的区域分析分馏公司)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 124    |    Report Code: BMIRE00027405    |    Category: Life Sciences

South America Blood Transfusion Diagnostics Market

SAM 输血诊断市场预计将从 2022 年的 2.1755 亿美元增长到 2028 年的 3.0289 亿美元。预计 2022 年至 2028 年复合年增长率为 5.7%。

输血诊断技术发展

输血诊断通常在肾移植等长时间手术和紧急情况下进行。这些手术可能会导致失血过多,因此很难用新鲜血液来弥补失血,尤其是在稀有血型的情况下。由于需求充足,输血诊断市场的主要参与者提供先进的全自动输血诊断,以减少人为干预。例如,2019 年 4 月,BD 推出了 BD BACTEC 质量控制介质,以帮助识别输血过程中受污染的血小板单位。此外,许多公司还采取战略活动,例如收购、合作和其他活动来占领市场。例如,2019 年 12 月,Getinge 收购了 Applikon Biotechnology,该公司是开发和供应从实验室到工业规模的创新生物反应器系统的领导者。 2019 年 10 月,美敦力收购 AV Medical Technologies。因此,这些进步可能会在未来几年为输血诊断市场带来新趋势。

市场概述

巴西是 SAM 中最大的国家之一。它拥有完善的医疗器械行业,并受巴西国家卫生监督局(ANVISA)监管。同样,国家计量标准化和工业质量研究所 (INMETRO) 为该国医疗器械行业的公司制定标准和指南。巴西拥有该地区最重要的医疗设备产业,也是美国最大的医疗设备进口国,约 30% 的医疗设备从美国进口。此外,脓毒症在巴西是一个严重的健康问题,这种情况需要输血作为治疗方法。 2022年巴西SciELO发表的一项研究表明,巴西ICU脓毒症患病率为30%,而ICU患者的医院死亡率为55%。脓毒症造成重大负担的原因包括清洁水、卫生设施和营养不足;疫苗接种不足;获得重症监护服务的机会较少;医疗保健相关感染的发生率增加。因此,脓毒症患病率的不断上升是促进巴西输血诊断市场增长的因素之一。此外,根据巴西卫生部的数据,1.9%的巴西人口每年献血,约400万次献血。在巴西,每年采集约 300 万单位血液,公共系统约占这些地区捐献的 70%。因此,上述因素推动了巴西对输血诊断的需求。

SAM 输血诊断市场收入及预测至 2028 年(百万美元)  ;

SAM 输血诊断市场细分

SAM 输血诊断市场根据产品、应用、最终用户和国家进行细分。

  • 根据产品,SAM 输血诊断市场分为仪器和设备。试剂盒和试剂。仪器和设备到 2022 年,试剂盒细分市场将占据更大的市场份额。
  •  根据应用,SAM 输血诊断市场分为血液分组和疾病筛查。到 2022 年,疾病筛查领域将占据更大的市场份额。
  • 根据最终用户,SAM 输血诊断市场细分为医院、诊断实验室、血库和血浆分离公司。血库细分市场在 2022 年占据主导地位。
  • 根据国家/地区,SAM 输血诊断市场分为巴西、阿根廷和 SAM 的其余部分。我们的区域分析表明,巴西将在 2022 年占据市场主导地位。

雅培; BAG 诊断有限公司; Bio-Rad 实验室公司; DiaSorin SpA; F.霍夫曼-拉罗氏有限公司;南澳州格里福斯; Immucor 有限公司; Ortho 临床诊断(QuidelOrtho 公司);商数有限;和 Thermo Fisher Scientific Inc. 是 SAM 输血诊断市场的领先公司。



South America Blood Transfusion Diagnostics Strategic Insights

Strategic insights for South America Blood Transfusion Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-america-blood-transfusion-diagnostics-market-strategic-framework.webp
Get more information on this report

South America Blood Transfusion Diagnostics Report Scope

Report Attribute Details
Market size in 2022 US$ 217.55 Million
Market Size by 2028 US$ 302.89 Million
Global CAGR (2022 - 2028) 5.7%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 产品
  • 仪器及套件
  • 试剂
By 应用
  • 血型鉴定
  • 疾病筛查
By 最终用户
  • 医院
  • 诊断实验室
  • 血库
  • 血浆分离公司
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Abbott
  • BAG Diagnostics GmbH
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Grifols, S.A.
  • Immucor, Inc.
  • Ortho Clinical Diagnostics (QuidelOrtho Corporation)
  • Quotient Limited
  • Thermo Fisher Scientific Inc.
  • Get more information on this report

    South America Blood Transfusion Diagnostics Regional Insights

    The regional scope of South America Blood Transfusion Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-america-blood-transfusion-diagnostics-market-geography.webp
    Get more information on this report

    The List of Companies - South America Blood Transfusion Diagnostics Market

    1. Abbott
    2. BAG Diagnostics GmbH
    3. Bio-Rad Laboratories, Inc.
    4. DiaSorin S.p.A.
    5. F. Hoffmann-La Roche Ltd      
    6. Grifols, S.A.  
    7. Immucor, Inc.  
    8. Ortho Clinical Diagnostics (QuidelOrtho Corporation)
    9. Quotient Limited
    10. Thermo Fisher Scientific Inc.  
    Frequently Asked Questions
    How big is the South America Blood Transfusion Diagnostics Market?

    The South America Blood Transfusion Diagnostics Market is valued at US$ 217.55 Million in 2022, it is projected to reach US$ 302.89 Million by 2028.

    What is the CAGR for South America Blood Transfusion Diagnostics Market by (2022 - 2028)?

    As per our report South America Blood Transfusion Diagnostics Market, the market size is valued at US$ 217.55 Million in 2022, projecting it to reach US$ 302.89 Million by 2028. This translates to a CAGR of approximately 5.7% during the forecast period.

    What segments are covered in this report?

    The South America Blood Transfusion Diagnostics Market report typically cover these key segments-

  • 产品 (仪器及套件, 试剂)
  • 应用 (血型鉴定, 疾病筛查)
  • 最终用户 (医院, 诊断实验室, 血库, 血浆分离公司)
  • What is the historic period, base year, and forecast period taken for South America Blood Transfusion Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Blood Transfusion Diagnostics Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in South America Blood Transfusion Diagnostics Market?

    The South America Blood Transfusion Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • BAG Diagnostics GmbH
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd
  • Grifols, S.A.
  • Immucor, Inc.
  • Ortho Clinical Diagnostics (QuidelOrtho Corporation)
  • Quotient Limited
  • Thermo Fisher Scientific Inc.
  • Who should buy this report?

    The South America Blood Transfusion Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Blood Transfusion Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.